Gupta, Latika Gasparyan, Armen Yuri Zimba, Olena Misra, Durga Prasanna
Published in
Rheumatology international
The evolving research landscape in the time of the Coronavirus disease 2019 (COVID-19) pandemic calls for greater understanding of the perceptions of scholars regarding the current state and future of publishing. An anonymised and validated e-survey featuring 30 questions was circulated among rheumatologists and other specialists over social media ...
Milchert, Marcin Brzosko, Marek
Published in
Rheumatology international
The long-term mortality in giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) is unexpectedly decreased or at least not increased regardless of several mortality risk factors that these diseases share with other chronic immune-mediated rheumatic diseases. The genetic and immunological profile of PMR/GCA patients is unique, therefore, the h...
Lindner, Lisa Callhoff, Johanna Alten, Rieke Krause, Andreas Ochs, Wolfgang Zink, Angela Albrecht, Katinka
Published in
Rheumatology International
Osteoporosis is a frequent comorbidity in rheumatoid arthritis (RA). Due to the improved treatment options for RA, we expect a long-term decrease in osteoporosis as an accompanying disease. Data from the German National Database (NDB) were used to investigate whether the frequency of osteoporosis has changed in the last 10 years. From 2007 to 2017,...
Naveen, R. Sundaram, T. G. Agarwal, Vikas Gupta, Latika
Published in
Rheumatology International
Teleconsultation has assumed a central role in the management of chronic and disabling rheumatic diseases, such as the idiopathic inflammatory myopathies (IIM), during COVID-19. However, the feasibility, challenges encountered, and outcomes remain largely unexplored. Here, we describe our teleconsultation experience in a prospectively followed coho...
Abualfadl, Esam Ismail, Faten Shereef, Rawhya R. El Hassan, Eman Tharwat, Samar Mohamed, Eman F. Abda, Essam A. Radwan, Ahmed R. Fawzy, Rasha M. Moshrif, Abdel Hafeez
...
Published in
Rheumatology International
During the coronavirus disease-2019 (COVID-19) pandemic there were several barriers to treatment access and medication adherence in rheumatoid arthritis (RA) patients. There is no information regarding the RA patient health status in Egypt during the COVID-19. Thus,the aim of this work was to study the impact of the pandemic on RA patients through ...
Woźniak-Roszkowska, Ewa Maślińska, Maria Gierej, Piotr Noszczyk, Bartłomiej
Published in
Rheumatology international
Autoimmune syndrome induced by adjuvants (ASIA) is the spectrum of diseases in which the substances considered inert to the body induce autoimmune reactions and inflammation. Some of the biomaterials recently used in plastic surgery, such as silicone or polyacrylamide hydrogel (PAAG) seem to trigger clinical features of ASIA. The aim of this study ...
Dey, Mrinalini Zhao, Sizheng Steven
Published in
Rheumatology International
Patient and public involvement is essential in the design and implementation of research studies to ensure research remains relevant and in line with public priorities. Public views on a given area of research may be sought via platforms such as focus groups or surveys. Here, we present the use of an openly available Google search data query tool, ...
Kardeş, Sinan Kuzu, Ali Suat Raiker, Rahul Pakhchanian, Haig Karagülle, Mine
Published in
Rheumatology International
To evaluate the public interest in rheumatic diseases during the coronavirus disease 2019 (COVID-19) pandemic. Google Trends was queried to analyze search trends in the United States for numerous rheumatic diseases and also the interest in a rheumatologist. Three 8-week periods in 2020 ((March 15–May 9), (May 10–July 4), and (July 5–August 29)) wer...
Giardina, F. Izzo, R. Gattamelata, A. Colafrancesco, S. Conti, F. Priori, R.
Published in
Rheumatology International
Cansu, Döndü Üsküdar Teke, Hava Üsküdar Arik, Deniz Korkmaz, Cengiz
Published in
Rheumatology International
Amyloidosis is described by the deposition of misfolded proteins in the tissues. Amyloidoses are classified into two as systemic and localized. Out of the systemic forms, AL (light chain) amyloidosis is the most prevalent type; however, amyloid A (AA) amyloidosis is more frequently encountered in the rheumatology practice. AA amyloidosis stands out...
